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TO THE EDITOR
Palmoplantar keratodermas (PPKs) are a
group of rare keratinization disorders
characterized by the excessive forma-
tion of keratin on the palms and soles.
Four clinical types of PPK can be classi-
fied by the pattern of lesions: diffuse,
punctuate, focal, and striate (Stevens
et al., 1996). Punctate palmo-
plantar keratoderma type I (PPKP1,
MIM number 148,600) is an autosomal
dominant inherited subtype of PPK
characterized by multiple tiny punctate
keratoses on the palms and soles, which
can gradually increase in diameter with
age and even coalesce (Figure 1a and b).
The incidence of this disease was
reported as 1.17 per 100,000 population
in Croatia and 3.3 per 100,000 popula-
tion in Slovenia (Guo et al., 2012). Two
linkage loci for PPKP1 (8q24.13–
8q24.21, 15q22.2–15q24.1) have been
reported previously (Martinez-Mir et al.,
2003; Zhang et al., 2004; Gao et al.,
2005; El Amri et al., 2010; Mamai et al.,
2012).
In recent years, the success of exome
sequencing has been well esta-
blished in the identification of novel
causal mutations for Mendelian diseases
(Ku et al., 2012). Here, we subjected
two DNA sequences (III8 and III9) from
the Chinese PPKP1 family linked to
15q22 (Family 22) to exome sequen-
cing. Informed consent was obtained
from all the sequenced participants.
This study was authorized by the Ethics
Committee of Anhui Medical University
and was conducted in accordance with
the Declaration of Helsinki Principles.
Exome capture and enrichment were
performed using the Agilent SureSelect
Human All Exon Kit (in solution; Santa
Clara, CA) according to the manu-
facturer’s protocols. Exome sequencing
was then performed on a HiSeq 2000
platform (Illumina, San Diego, CA), and
sequence data were processed to raw
sequence reads. These reads were
aligned to a human reference genome
(NCBI build 37.3, hg19), and the
analytical pipeline was then followed
by SOAPsnp (Li et al., 2009). Finally,
the variants were annotated to obtain
information such as genomic position
and functional effect.
On average, two sequences were
obtained from each individual at B50-
fold coverage depth. We obtained 4.51
billion bases of sequence data as paired-
end, 90-bp reads. After discarding reads
that had a duplicated start site, 2.69
billion bases of mappable targeted
exome were defined by RefSeq genes.
An average of 89.2% of the exome
was covered at least B10-fold, and
51,819 variants were identified per
individual.
We primarily focused on coding
variants, including non-synonymous
variants, splice-site variants, and inser-
tions/deletions, of which there were an
average of 11,362. We filtered the
variants against dbSNP129, eight Hap-
Map individuals, the 1,000 Genomes
Project, the YH database, and unaf-
fected individual, and reduced the
number of candidate variants to 527.
We then used SIFT to predict the func-
tional impact and determine the 261
variants that were the most likely to be
damaging. Finally, we found that five
mutations in five genes (DAPK2,
IGDCC4, RPL4, TPM1, and AAGAB)
were located on 15q22.2–15q24.1.
Among the five genes, mutations in
AAGAB have recently been identified
in PPKP1 in two publications (Giehl
et al., 2012; Pohler et al., 2012). We
tested all the samples and identified the
c.552_554TAG4AT mutation in exon 6
of AAGAB as the causative mutation in
Family 22 (Figure 1c and d). This muta-
tion resulted in a stop codon at amino
acid position 188 (p.Phe184 Leufs* 6).
We then sequenced all the exons and
exon–intron boundaries of AAGAB in
59 individuals from an additional seven
families (Families 23–29) and 28
sporadic patients (Sporadic patients
1–28) with PPKP1 (Supplementary
Figure S1 online). Finally, four truncated
mutations in four respective families and
a splice-site mutation in one sporadic
case were identified (Supplementary
Figure S2 online). The AAGAB gene
mutations were absent in three other
PPKP1 families (Families 27–29) and
27 sporadic patients (Sporadic patients
2–28). In addition, we identified the
c.481C4T mutation in exon 5 in one
patient with cancer from Family 24,Accepted article preview online 30 April 2013; published online 13 June 2013
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whereas none of three sporadic patients
with cancer carried mutations. There
appeared to be no genetic link between
AAGAB mutations and cancer.
To date, fourteen mutations in
AAGAB have been identified in PPKP1
patients with different ancestries,
including Scottish, Irish, Japanese, Tuni-
sian, Croatian, German, and Chinese
origins (Giehl et al., 2012; Pohler et al.,
2012). Table 1 lists all mutation types
and the categorized domain proteins.
The positions of protein alterations
are shown (Supplementary Figure S3
online). These data further indicate that
AAGAB is a major genetic factor in
PPKP1.
AAGAB encodes a- and g-adaptin-
binding protein p34, which contains
315 amino acids. An immunolocaliza-
tion study revealed that p34 usually acts
as a ligand for the NH2-terminal
domains of a-adaptin and g-adaptin.
These two adaptins are present in two
types of soluble adaptor complexes,
AP-1 and AP-2. p34 can colocalize with
cytosolic AP-1/AP-2 to help recruit
soluble adaptors to membranes (Page
et al., 1999). In addition, AP-2 acts as a
ligand for the EGFR, which has been
implicated in entry into the endosomal
system (Rappoport and Simon 2009).
Studies have revealed that AAGAB
knockdown in HaCaT cells increases
active EGFR signaling by 420-fold and
that p34 deficiency inhibits binding with
cytosolic AP-2, decreases EGFR protein
turnover, and recycles the receptor to
the cell surface (Pohler et al., 2012).
EGFR appears to be closely associated
with p34 to balance the normal
endocytic recycling of receptor
tyrosine kinases, which have been
implicated in the regulation of cell
proliferation.
In the current study, we identified six
mutations in the AAGAB gene in
Chinese PPKP1 patients. However, the
gene collectively accounts for only a
fraction of cases. Other genes carrying
mutations will be identified in the unre-
solved patients. As the widespread and
cost-effective use of exome sequencing
increases, it is proving to be a
powerful strategy for identifying specific
mutations in individuals.
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Figure 1. Clinical features of the proband and the mutation in AAGAB identified in Family 22. (a, b) The punctate keratoses on palms and soles of the proband.
(c, d) The frameshift mutation c.552_554TAG4AT (black arrow) identified in exon 6 of AAGAB.
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TO THE EDITOR
Generalized pustular psoriasis (GPP)
is a rare disorder affecting about 2 per
million individuals in Europe (Augey
et al., 2006). This severe disease is
characterized by repeated flare-ups
of pustules and can be accompanied
by a potentially life-threatening multisy-
stemic inflammation. Recently, missense
mutations in IL36RN have been
identified in GPP patients from Tunisia
and Europe (Marrakchi et al., 2011;
Onoufriadis et al., 2011). In addition,
a stop mutation, a novel missense
mutation, and mutations affecting
splicing of exon 3 have been observed
in Japanese patients (Sugiura et al.,
2012; Farooq et al., 2013). IL36RN’s
product IL36RA antagonizing three
cytokines of the IL1-family (Blumberg
et al., 2010) and therapy with a
recombinant interleukin-1 receptor
antagonist (anakinra) being effective in
some GPP patients (Viguier et al., 2010)
independently support the role of
IL36RN as a disease-causing gene.
A group of 19 patients were recruited
at five German university hospitals and
one specialized dermatology hospital. In
all, 17 patients suffered from typical
symptoms of GPP, one patient from
psoriasis vulgaris (PsV) with repeated
flares of generalized grouped pustules
without fever (ID P18, Table 1), and
another one from PsV with pustules
(P19). The study, approved by the ethi-
cal committee of the University of
Erlangen, was conducted according to
the Declaration of Helsinki principles.
All patients/legal guardians gave written
informed consent. Patients were
screened for mutations in coding exons
2–5 of IL36RN by Sanger sequencing;
mutations were named according to
reference sequence NM_173170. In
cases of no point mutation/homozygous
mutations without available parents,
MLPA (multiplex ligation-dependent
probe amplification, MRC Holland,
(Schouten et al., 2002)) as a quanti-
tative analysis was performed with self-
designed oligonucleotides for coding
exons. The three-dimensional structure
of human IL36RA was modeled with
SwissModel (Guex et al., 2009) using
the high-resolution crystal structure of
murine IL-1F5 as a template (PDB
code: 1MD6; Dunn et al., 2003).
Promising variants possibly affecting
the structure of IL36RA were
generated with SwissModel (Guex
et al., 2009), selecting the lowest-
energy rotamer for each mutated side
chain. Structure analysis and visualiza-
tion was performed with RasMol
(Sayle and Milner-White, 1995).
The majority of GPP patients were
female (68.4%; Table 1). We identified
homozygous/compound heterozygous
variants in seven patients: four patients
were homozygous for p.His32Arg,
p.Pro76Leu, or p.Ser113Leu, and three
further individuals were compound
heterozygous for p.Ser113Leu and either
p.Arg48Trp, p.Glu94X, or p.Pro76Leu.
The stop mutation and the two missense
variants p.His32Arg and p.Pro76Leu
were, to our knowledge, previously
unreported, all affecting highly con-
served residues. p.Glu94X disrupted
the globular cytokine fold (Figure 1b).
The lack of the C-terminal half of the
domain caused the loss of two -sheets
and an important disulfide bond that
fixed the relative orientation of the N
and C terminus. Pro76 was located at a
loop position at which a leucine could
not be accommodated owing to steric
clashes (Figure 1e and f), causing struc-
tural changes of the respective loop and/
or decreased protein stability. In the
case of p.Arg48Trp, the wild type’s
arginine formed both cation–pi stacking
interactions and a hydrogen bond with
Tyr89 (Figure 1c). Because of its bulki-
ness, the side chain of W48 adopted a
different orientation in the mutant,
resulting in a loss of stabilizing interac-
tions with Tyr89 (Figure 1d). Ser113
stabilized the local geometry by a
hydrogen bond with Tyr116 that could
not be formed in the mutant p.Ser113-
Leu (Figure 1g and h). In addition, the
Leu113 side chain formed clashes with
the side chain of Cys70. Interestingly,
the same residue was also affected by
clashes upon p.Pro76Leu (Figure 1f),
suggesting similar structural effects.
In contrast, His32 was oriented toward
the solvent; therefore, p.His32Arg was
not expected to have a significant effect
on IL36RA structure/stability, but it pos-
sibly has an effect on the interaction with
its receptor. As its respective structure is
unknown to date, the prediction was
based on the crystal structure of the
homologous IL-1 in complex with
IL1R (Vigers et al., 1997). Gln32 of
IL-1—structurally equivalent to His32
of IL-36RA—formed tight interactions
with the IL1 receptor (Figure 1i),
See related commentary on pg 2503
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